4.250EUR+1.55%Mkt Cap: 66.48M $P/E: —Today
THX Pharma Société Anonyme, a biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system disorders. It is involved in the development of Batten-1, an initial drug…